ES2000602A6 - Procedimiento para la preparacion de nuevos peptidos relacionados con la calcitonina - Google Patents

Procedimiento para la preparacion de nuevos peptidos relacionados con la calcitonina

Info

Publication number
ES2000602A6
ES2000602A6 ES8600959A ES8600959A ES2000602A6 ES 2000602 A6 ES2000602 A6 ES 2000602A6 ES 8600959 A ES8600959 A ES 8600959A ES 8600959 A ES8600959 A ES 8600959A ES 2000602 A6 ES2000602 A6 ES 2000602A6
Authority
ES
Spain
Prior art keywords
related peptide
peptide derivatives
calcitonin gene
gene related
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600959A
Other languages
English (en)
Inventor
Toshiharj Noda
Nobutaka Fujii
Kaorj Morita
Masayuki Hori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Publication of ES2000602A6 publication Critical patent/ES2000602A6/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57527Calcitonin gene related peptide
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE NUEVOS PEPTIDOS RELACIONADOS CON LA CALCITONINA. COMPRENDE SOMETER A CONDENSACION, POR LA TECNICA DE LA FASE LIQUIDA Y/O DE LA FASE SOLIDA LOS CORRESPONDIENTES AMINOACIDOS O PEPTIDOS PARCIALES CONSTITUTIVOS DEL PEPTIDO, SEGUIDO DE ELIMINACION DE LOS GRUPOS PROTECTORES MEDIANTE HIDROLISIS, DESCOMPOSICION CON ACIDO, REDUCCION, AMINOLISIS O HIDROGENOLISIS. ESTOS PEPTIDOS SON UTILES COMO MEDICINAS O AUXILIARES DE DIAGNOSTICO CLINICO PARA EL METABOLISMO DE LOS HUESOS Y EL SISTEMA NERVIOSO CENTRAL.
ES8600959A 1985-08-09 1986-08-08 Procedimiento para la preparacion de nuevos peptidos relacionados con la calcitonina Expired ES2000602A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP17534085 1985-08-09

Publications (1)

Publication Number Publication Date
ES2000602A6 true ES2000602A6 (es) 1988-03-01

Family

ID=15994349

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600959A Expired ES2000602A6 (es) 1985-08-09 1986-08-08 Procedimiento para la preparacion de nuevos peptidos relacionados con la calcitonina

Country Status (5)

Country Link
US (1) US4743677A (es)
EP (1) EP0212432B1 (es)
JP (1) JPS62129297A (es)
DE (1) DE3685167D1 (es)
ES (1) ES2000602A6 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049654A (en) * 1986-12-04 1991-09-17 Toyo Jozo Kabushiki Kaisha Calcitonin gene related peptide derivatives
JPS6426598A (en) * 1987-07-22 1989-01-27 Toyo Jozo Kk Calcitonin gene related peptide derivative
JPH02262595A (ja) * 1988-02-29 1990-10-25 Otsuka Pharmaceut Co Ltd ポリペプチド誘導体
EP0367463A1 (en) * 1988-10-20 1990-05-09 Celltech Limited Calcitonin gene related peptide analogues
DE3943519A1 (de) * 1989-04-27 1991-01-17 Stief Georg Arzneimittel zur behandlung erektiler dysfunktionen
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment
JPH0745517B2 (ja) * 1989-11-08 1995-05-17 ダイセル化学工業株式会社 ペプチド、および環状ペプチドの製造方法
CA2103703A1 (en) * 1991-02-12 1992-08-13 Michael J. Tyler Peptides
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
WO1992015317A1 (en) * 1991-03-08 1992-09-17 Amylin Pharmaceuticals, Inc. Synthetic preparation of amylin and amylin analogues
JP3821485B2 (ja) * 1995-03-20 2006-09-13 協和醗酵工業株式会社 新規カルシトニン誘導体
US5962270A (en) 1996-02-06 1999-10-05 Bionebraska, Inc. Recombinant preparation of calcitonin fragments and use thereof in the preparation of calcitonin and related analogs
AU3359697A (en) * 1996-07-08 1998-02-02 Yamanouchi Pharmaceutical Co., Ltd. Bone resorption inhibitors
US20010046955A1 (en) * 2000-03-14 2001-11-29 Gelfand Erwin W. Method for reducing allergen-induced airway hyperresponsiveness
KR100418962B1 (ko) * 2001-06-07 2004-02-14 김학주 2-(4-나이트로페닐설포닐)에톡시카르보닐-아미노산류를사용하여 펩티드를 고수율 및 고순도로 제조하는 방법
EP3069731A1 (en) 2005-11-14 2016-09-21 Labrys Biologics Inc. Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
RU2522493C2 (ru) 2008-03-04 2014-07-20 Пфайзер Лимитед Способы лечения хронической боли
CN102740884A (zh) 2009-08-28 2012-10-17 瑞纳神经科学公司 通过施用针对降钙素基因相关肽的拮抗性抗体来治疗内脏痛的方法
TWI705825B (zh) 2011-05-20 2020-10-01 美商艾爾德生物控股有限責任公司 抗降血鈣素基因相關胜肽(anti-cgrp)或抗降血鈣素基因相關胜肽受器(anti-cgrp-r)抗體或抗體片段治療或預防慢性及急性型腹瀉之用途
PE20141787A1 (es) 2011-05-20 2014-12-07 Alderbio Holdings Llc Composiciones anti-cgrp y uso de las mismas
CN107827982B (zh) 2011-05-20 2021-07-06 H.伦德贝克公司 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途
KR101855242B1 (ko) * 2012-01-26 2018-05-09 크리스토퍼 제이. 소레스 펩타이드 호르몬의 칼시토닌 cgrp 패밀리의 펩타이드 길항제 및 그의 용도
US20170114122A1 (en) 2015-10-23 2017-04-27 Alderbio Holdings Llc Regulation of glucose metabolism using anti-cgrp antibodies
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
AU2015230933B2 (en) 2014-03-21 2020-08-13 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
CA3035561A1 (en) 2016-09-02 2018-03-08 Christopher J. Soares Use of cgrp receptor antagonists in neuroprotection and neurological disorders
CN109952314A (zh) 2016-09-23 2019-06-28 泰瓦制药国际有限公司 治疗难治性偏头痛
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心) 一种太子参药材中氨基酸类成分的薄层鉴别方法
WO2020146527A1 (en) 2019-01-08 2020-07-16 Alder Biopharmaceuticals, Inc. Acute treatment and rapid treatment of headache using anti-cgrp antibodies
CA3077973A1 (en) 2020-04-06 2021-10-06 H. Lundbeck A/S Treatment of most bothersome symptom (mbs) associated with migraine using anti-cgrp antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4514331A (en) * 1983-06-29 1985-04-30 University Patents, Inc. Peptide hormones with calcitonin-like activity
US4549986A (en) * 1983-12-23 1985-10-29 The Salk Institute For Biological Studies Human CGRP

Also Published As

Publication number Publication date
EP0212432B1 (en) 1992-05-06
US4743677A (en) 1988-05-10
JPS62129297A (ja) 1987-06-11
EP0212432A2 (en) 1987-03-04
DE3685167D1 (de) 1992-06-11
EP0212432A3 (en) 1989-01-25

Similar Documents

Publication Publication Date Title
ES2000602A6 (es) Procedimiento para la preparacion de nuevos peptidos relacionados con la calcitonina
ES2070660A1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
NO875188L (no) Karbapenemderivater, fremgangsmaate til fremstilling derav, samt preparater som inneholder dem.
AU541843B2 (en) Substituted 1,2-diaminocyclobutene-3,4-diones
IL54930A (en) Herbicidal preparations containing 1,2,3-thiadiazole-5-carboxylic acid derivatives
ZA909903B (en) New compounds
EP0155786A3 (en) New peptide, and production and use thereof
AU674839B2 (en) Pyridinecarboximidamide compound and use thereof
EP0138344A3 (en) Pyridazinones as beta-adrenoceptor antagonists
ES8401930A1 (es) Un procedimiento para preparar derivados de amida del acido nitrobenzoico.
FR2471425B1 (fr) Dispositif cathodique pour four d'electrolyse ignee, notamment pour la production d'aluminium
JPS5430197A (en) Novel antibiotic compound
EP0295679A3 (en) Physiologically-active novel peptides
AU2377177A (en) ELECTROLYTIC DIAPHRAGM v, F'r L
EP0178845A3 (en) Peptide-substituted heterocyclic immunostimulants
PL270981A1 (en) Pesticide containing novel derivatives of 2-phenylimidazole
ES8304548A1 (es) "procedimiento de preparacion de derivados de fenetanolamina".
NZ217778A (en) Antiinflammatory compositions containing piroxicam
FR2679259B1 (fr) Dispositif d'orientation de raccords d'anodes.
PL261454A1 (en) Herbicide containing novel 2-aryl-4,5,6,7-tetrahydroisoindolinones
MY104318A (en) Novel thiopen compounds and their preparation
AU8143682A (en) Appareil d'electrolyse
IL65528A0 (en) 5-acyloxy-4(5h)-oxazolonium salts,their preparation and their use as intermediates for the synthesis of herbicidally active triazinones
JPS5283732A (en) Haloazetidinone compounds
PH15358A (en) 3'-(substituted phenyl)-spiro-(x sobenzofuran-1(3h),5'(4'h)-isoxazol)-3-ones

Legal Events

Date Code Title Description
PC1A Transfer granted

Owner name: ASAHI KASEI KABUSHIKI KAISHA